Phenomix Corporation · San Diego, CA United States
| 5871 Oberlin Dr., Ste. 200 | Phone: 858-731-5200 |
| San Diego, CA | Fax: 858-731-5225 |
| 92121 | |
| United States | 
Map This Company |
Phenomix Corporation Rankings
Company Description
Phenomix hopes to create a pharmaceutical phenomenon by investigating and discovering new treatments for immune system ailments and metabolic diseases. The drug development company's lead product candidate dutogliptin is an oral-dose treatment aiming to stabilize glucose levels in patients with Type 2 diabetes. Other pipeline candidates target infectious and autoimmune diseases, including hepatitis C and certain types of cancer. The biotechnology firm's drug candidates focus on inhibiting complex proteins (enzymes) that promote disease within the body. The company is owned by a number of private investors.
Phenomix Corporation Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PrivateSingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 34 |
Executives
14 executives listed for Phenomix Corporation's San Diego, CA location.
| CEO and Director | Laura Shawver | |
|---|---|---|
| President | Julie Cherrington | |
| VP Finance | Brian Baker |